More clinical trials. Surely they could impliment on the back of CE Marking - what use is the approval if hospitals need further proof.
Anyway, still good news though.
Ann: ResApp Builds European Market Presence, page-3
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #